North America to Dominate Acne Treatment Market

According to the latest revised industry analysis from Persistence Market Research, the global acne treatment market is valued at over US $ 5.8 billion in 2020 and is expected to grow at a CAGR of nearly 6% over the course of the forecast period (2021-2031). In the United States, acne affects approximately 50 million people each year. One of the major factors driving the growth of the market in the world is the increase in the rate of skin diseases. Acne is most commonly seen in teenagers, but can also be seen in people of all age groups. According to the American Academy of Dermatology Association, more than 85% of the population aged 12 to 24 have suffered from minor acne at least once or twice, and this can continue in people in their 30s and 40s.

To stay ahead of your competition, request a sample @

https://www.persistencemarketresearch.com/samples/5279

The significant prevalence of acne has led to an increased awareness to consider skin treatment. This, in turn, is expected to fuel the demand for acne treatment products. As new drugs and treatments are needed to replace old methods such as antibiotics, acne research and development is generating leads and opportunities for market players. As a result, various industry players receive approvals from regulatory authorities. Some of the recent approvals include AKLIEF (trifarotene) cream 0.005% (October 2019, Galderma SA), ARAZLO (tazarotene) lotion, 0.045% (Bausch Health Companies Inc., December 2019) and ACZONE (DAPSONE) GEL (September 2019, Almirall HER). Thus, the increasing approvals support a positive outlook for healthy and continued market growth.

Key points of the market research
• Per treatment, retinoid therapy will hold around 40% market share in global value, mainly due to its effectiveness in controlling the spread of acne compared to other products and reducing the formation of scars. acne.
• Based on route of administration, topical route of administration is leading with over 60% market share. The ease of application and the greater availability of lotions, creams and gels are positively stimulating the demand for topical products.
• Inflammatory acne is estimated to dominate the market by type. This segment represented around 53% of the market share. The significant scarring and pain associated with this type of acne is a key factor in the segment.

For critical insight into this market, ask an expert here @

https://www.persistencemarketresearch.com/ask-an-expert/5279
• Inflammatory acne is estimated to dominate the market by type. This segment represented around 53% of the market share. Significant scars and pain associated with this type of acne are a key factor in the segment.
• Institutional sales dominate acne treatment with a 52% market share. The growing number of dermatology clinics and the growing preference for in-office acne treatment procedures to achieve faster results have created a positive impact on the growth of the market.
• By region, North America is expected to dominate the global acne treatment market with a value share of around 44%.
Europe is expected to be the second largest region with a 20% value share during the forecast period.

Competition in the market
New product launches and approvals, agreements, collaborations and partnerships have become the key growth strategy adopted by industry players. By focusing on these strategies, key stakeholders are expanding their geographic footprint and strengthening their existing product portfolios.
• In January 2021, Eligo Biosciences SA and GlaxoSmithKline PLC entered into a research collaboration to develop gene therapies to treat or prevent the growth of normal acne.
• In February 2020, Almirall SA entered into a licensing agreement with Paratek Pharmaceuticals, Inc. to expand Seysara from Almirall into the Chinese market.

For an in-depth competitive analysis, buy now @

https://www.persistencemarketresearch.com/checkout/5279

Contact us:
Persistence market research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
US Phone – + 1-646-568-7751
United States-Canada Toll Free – +1 800-961-0353
Sales – [email protected]

About Us
Persistence Market Research is here to provide businesses with a one stop solution to improve customer experience. It is committed to gathering the appropriate feedback after going through personalized interactions with customers to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. “. The best possible returns are guaranteed there.

This version was posted on openPR.

Source link

About Sally Dominguez

Check Also

Stevia: How healthy is this ingredient that dieticians recognize as a safer alternative to sugar?

Sugar is made up of carbon while stevia is organic in composition. | Photo credit: …

Leave a Reply

Your email address will not be published. Required fields are marked *